Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Br J Anaesth ; 128(4): 608-609, 2022 04.
Artículo en Inglés | MEDLINE | ID: mdl-35183348

RESUMEN

Despite the clear benefits of vaccination against COVID-19, there was significant unease relating to the government policy of mandatory vaccination of health and care staff in England and the potential inequities this may lead to. Healthcare staff, and in particular doctors, speaking out on this issue may have inadvertently provided a narrative, which undermined the objective of achieving widespread vaccination of populations against this serious disease. The recent reversal of this policy may not mark the end of this debate amongst health and social care staff.


Asunto(s)
COVID-19 , Médicos , COVID-19/prevención & control , Inglaterra/epidemiología , Humanos , Medicina Estatal , Vacunación
2.
Curr Opin Anaesthesiol ; 33(3): 448-453, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32371637

RESUMEN

PURPOSE OF REVIEW: Perioperative hypersensitivity reactions can pose diagnostic and management challenges for the anaesthetist. Difficulties in diagnosing hypersensitivity reactions in the perioperative setting are highlighted and recommendations from recent guidelines on the acute management of life-threatening anaphylaxis are presented. RECENT FINDINGS: Anaesthetists play a key role in investigating perioperative hypersensitivity reactions. During a suspected perioperative hypersensitivity event, a serum tryptase level should be measured to help with subsequent allergy investigation. Moreover, anaesthetists can ensure that a high-quality referral is made to allergy clinics by providing thorough documentation of the events, detailing symptoms, treatments, and the chronology of drug administrations. SUMMARY: Perioperative hypersensitivity reactions are rare but can be life-threatening. A high index of suspicion should be maintained for their successful management. Whenever a perioperative hypersensitivity reaction is suspected, close collaboration between anaesthetist and the allergy team investigating the patient is paramount, in order for the patient to be appropriately investigated and have an uneventful anaesthetic in the future.


Asunto(s)
Anafilaxia/inducido químicamente , Anestésicos/efectos adversos , Anestesistas/psicología , Hipersensibilidad a las Drogas , Hipnóticos y Sedantes/efectos adversos , Cuidados Preoperatorios , Humanos , Periodo Perioperatorio , Factores de Riesgo
3.
Br J Anaesth ; 123(1): e16-e28, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-30916015

RESUMEN

Suspected perioperative hypersensitivity reactions are rare but contribute significantly to the morbidity and mortality of surgical procedures. Recent publications have highlighted the differences between countries concerning the respective risk of different drugs, and changes in patterns of causal agents and the emergence of new allergens. This review summarises recent information on the epidemiology of perioperative hypersensitivity reactions, with specific consideration of differences between geographic areas for the most frequently involved offending agents.


Asunto(s)
Anafilaxia/epidemiología , Complicaciones Intraoperatorias/epidemiología , Complicaciones Posoperatorias/epidemiología , Humanos
4.
Curr Opin Allergy Clin Immunol ; 19(4): 266-271, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31247633

RESUMEN

PURPOSE OF REVIEW: This review aims to describe current best practice and recent advances in the use of risk stratification as a tool for drug provocation testing (DPT). In particular, we focus on the testing of unsubstantiated penicillin allergy labels. RECENT FINDINGS: The inherent risks of DPT are mitigated through careful selection of patients. A detailed history will elicit features of a potentially severe index reaction, as well as significant patient comorbidities which may increase the risks associated with DPT. Such patients require skin testing and/or in vitro testing prior to consideration for a DPT. However, there is increasing evidence that patients without these features may be able to proceed directly to DPT. This has been demonstrated extensively with unsubstantiated penicillin allergy labels, and a variety of risk stratification models have been employed to identify the 'low-risk' patient. Improved outcomes and reduced cost have been demonstrated with such models without compromising patient safety. SUMMARY: Risk stratification tools may enable well-tolerated and effective 'delabelling' of low-risk patients, with less demand on already scarce resources.


Asunto(s)
Hipersensibilidad a las Drogas/diagnóstico , Inmunización/métodos , Selección de Paciente , Administración Oral , Alérgenos/inmunología , Animales , Humanos , Anamnesis , Penicilinas/inmunología , Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA